CRDF – cardiff oncology, inc. (US:NASDAQ)

News

Cardiff Oncology (CRDF) was upgraded by Wall Street Zen from "sell" t
Cardiff Oncology to Participate in Three Upcoming Investor Conferences [Yahoo! Finance]
Cardiff Oncology to Participate in Three Upcoming Investor Conferences 
Cardiff Oncology Spotlights Onvansertib Data at Oppenheimer: 72% ORR in RAS-Mutant mCRC [Yahoo! Finance]
Cardiff Oncology (CRDF) had its price target lowered by Piper Sandler from $10.00 to $6.00. They now have an "overweight" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com